About OrthogenRx
OrthogenRx is a company based in Doylestown (United States) founded in 2012 was acquired by Avanos in December 2021. OrthogenRx has raised $1.19 million across 4 funding rounds from investors including Avanos and Ben Franklin Technology Partners. The company has 1,522 employees as of December 31, 2017. OrthogenRx operates in a competitive market with competitors including Miach Orthopaedics, Rotation Medical, Cayenne Medical, Biorez and OrthoSpace, among others.
- Headquarter Doylestown, United States
- Employees 1522 as on 31 Dec, 2017
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of OrthogenRx
Unlock access to complete
Unlock access to complete
Funding Insights of OrthogenRx
OrthogenRx has successfully raised a total of $1.19M across 4 strategic funding rounds. The most recent funding activity was a Seed round of $300 thousand completed in March 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in OrthogenRx
OrthogenRx has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Avanos and Ben Franklin Technology Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Technology ecosystem growth is supported in Southeastern Pennsylvania.
|
Locked | Locked | Locked | |
|
Medical devices for pain management and enteral feeding are manufactured.
|
Locked | Locked | Locked |
Investor details for OrthogenRx
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by OrthogenRx
Investment portfolio details for OrthogenRx
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - OrthogenRx
Detailed financials for OrthogenRx
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Orthogenrx Comparisons
Peer comparison for OrthogenRx
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of OrthogenRx
OrthogenRx operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Miach Orthopaedics, Rotation Medical, Cayenne Medical, Biorez and OrthoSpace, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Bio-engineered surgical implants for connective tissue repair are developed.
|
|
| Locked | Locked | Locked |
A rotator cuff repair system is developed for disease treatment.
|
|
| Locked | Locked | Locked |
Soft tissue reconstruction solutions for knee and shoulder
|
|
| Locked | Locked | Locked |
Bioresorbable scaffolds for ACL soft tissue regeneration are developed.
|
|
| Locked | Locked | Locked |
Biodegradable balloon system for rotator cuff tear
|
|
| Locked | Locked | Locked |
3D-printed implants are developed for treating joint injuries.
|
Detailed competitors of OrthogenRx
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Orthogenrx
Complete news archive for OrthogenRx
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about OrthogenRx
OrthogenRx was founded in 2012 and raised its 1st funding round 1 year after it was founded.
OrthogenRx is headquartered in Doylestown, United States. It is registered at Doylestown, Pennsylvania, United States.
OrthogenRx is a funded company, having raised a total of $1.19M across 4 funding rounds to date.
As of Dec 31, 2017, the latest employee count at OrthogenRx is 1,522.
OrthogenRx was founded in 2012 in Doylestown, United States, where late-stage development of generic Class III medical devices in orthopedics is conducted. A product portfolio is maintained in the musculoskeletal sector, encompassing rheumatology, physiatry, orthopedics, and sports medicine specialties. Backing from Ben Franklin Technology Partners has been secured, including 175K in funding. Operations center on generic devices for these therapeutic areas.
OrthogenRx's top competitors include Miach Orthopaedics, Nanochon and ZuriMED Technologies.
OrthogenRx has 2 investors. Key investors include Avanos, and Ben Franklin Technology Partners.